Icli, F. Et Al. 2005. Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: A randomised phase III trial of Turkish Oncology Group. British Journal of Cancer , vol.92, no.4 , 639-644.

Icli, F., Akbulut, H., Uner, A., Yalcin, B., Baltali, E., Altinbas, M., ... Coşkun, Ş.(2005). Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: A randomised phase III trial of Turkish Oncology Group. British Journal of Cancer , vol.92, no.4, 639-644.

Icli, F. Et Al. "Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: A randomised phase III trial of Turkish Oncology Group," British Journal of Cancer , vol.92, no.4, 639-644, 2005

Icli, F. Et Al. "Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: A randomised phase III trial of Turkish Oncology Group." British Journal of Cancer , vol.92, no.4, pp.639-644, 2005

Icli, F. Et Al. (2005) . "Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: A randomised phase III trial of Turkish Oncology Group." British Journal of Cancer , vol.92, no.4, pp.639-644.

@article{article, author={F. Icli Et Al. }, title={Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: A randomised phase III trial of Turkish Oncology Group}, journal={British Journal of Cancer}, year=2005, pages={639-644} }